![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MT Slawsky and NA Castle
Cardiology Section, Department of Veterans Affairs Medical Center, Boston, Massachusetts.
The K+ channel blocking action of the class Ic antiarrhythmic agent flecainide was compared with that of propafenone and quinidine in isolated adult rat ventricular myocytes by using the whole-cell patch- clamp technique. In rat ventricular myocytes, depolarization activates both an inactivating (ITO) and a maintained (IK) outward K+ current. Flecainide, propafenone and quinidine all were potent inhibitors of ITO with IC50s of 3.7, 3.3 and 3.9 microM, respectively. Flecainide and quinidine were less potent inhibitors of IK than was propafenone with IC50s of 15 and 14 microM compared with an IC50 of 5 microM for propafenone. By contrast with their effects on outward currents, these agents produced little or no inhibition of the inward rectifier K+ current, even when present at 300 microM. All three agents produced a concentration-dependent increase in the rate of inactivation of ITO but they only produced minor hyperpolarizing shifts (approximately 3 mV) in the voltage dependence of steady-state inactivation. Although propafenone had little effect on the rate of ITO recovery from inactivation (tau CONTROL = 64 +/- 5 ms; tau PROPAFENONE = 84 +/- 9 ms), ITO recovery in the presence of flecainide and quinidine was biexponential; it exhibited an additional slow component (tau FAST = 67 +/- 5 ms and tau SLOW = 2580 +/- 1500 ms for flecainide; tau FAST = 55 +/- 5 ms and tau SLOW = 871 +/- 99 ms for quinidine). Consistent with these observations, flecainide and quinidine, but not propafenone, produced use-dependent block of ITO at a stimulation frequency of 1 Hz.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  R. Veeraraghavan and S. Poelzing Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge Cardiovasc Res, March 1, 2008; 77(4): 749 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Stokoe, R. Balasubramaniam, C. A. Goddard, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/ murine hearts modelling the Brugada syndrome J. Physiol., May 15, 2007; 581(1): 255 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vecchietti, E. Grandi, S. Severi, I. Rivolta, C. Napolitano, S. G. Priori, and S. Cavalcanti In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H56 - H65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Akar, R. C. Wu, I. Deschenes, A. A. Armoundas, V. Piacentino III, S. R. Houser, and G. F. Tomaselli Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H602 - H609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Cahill and G. J. Gross Propafenone and Its Metabolites Preferentially Inhibit IKrin Rabbit Ventricular Myocytes J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 59 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Arias, T. Gonzalez, I. Moreno, R. Caballero, E. Delpon, J. Tamargo, and C. Valenzuela Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels Cardiovasc Res, March 1, 2003; 57(3): 660 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lin, Z. Wang, and D. Fedida Influence of permeating ions on Kv1.5 channel block by nifedipine Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1160 - H1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lei, H. Honjo, I. Kodama, and M.R. Boyett Characterisation of the transient outward K+ current in rabbit sinoatrial node cells Cardiovasc Res, June 1, 2000; 46(3): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Sanchez-Chapula Mechanism of Transient Outward K+ Channel Block by Disopyramide J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 515 - 523. [Abstract] [Full Text]
|
|
|
|
|
|
H. M. Himmel, E. Wettwer, Q. Li, and U. Ravens Four different components contribute to outward current in rat ventricular myocytes Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H107 - H118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Snyders Structure and function of cardiac potassium channels Cardiovasc Res, May 1, 1999; 42(2): 377 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Nenov, W. J. Crumb Jr, J. D. Pigott, L. H. Harrison Jr, and C. W. Clarkson Quinidine Interactions With Human Atrial Potassium Channels : Developmental Aspects Circ. Res., December 14, 1998; 83(12): 1224 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Cogolludo, F. Perez-Vizcaino, and J. Tamargo Antagonism by Class I Antiarrhythmic Drugs of Levcromakalim-Induced Relaxation in Isolated Rat Aorta J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 81 - 86. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Rasmusson, M. J. Morales, S. Wang, S. Liu, D. L. Campbell, M. V. Brahmajothi, and H. C. Strauss Inactivation of Voltage-Gated Cardiac K+ Channels Circ. Res., April 20, 1998; 82(7): 739 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. W. Anderson, and D. Fedida J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1247 - 1256. [Abstract] [Full Text]
|
|
|
|
|
|
R. Coronel, T. Opthof, P. Taggart, J. Tytgat, and M. Veldkamp Differential electrophysiology of repolarisation from clone to clinic Cardiovasc Res, March 1, 1997; 33(3): 503 - 517. [PDF]
|
|
|
|
|
|
S. W. Yeola and D. J. Snyders Electrophysiological and pharmacological correspondence between Kv4.2 current and rat cardiac transient outward current Cardiovasc Res, March 1, 1997; 33(3): 540 - 547. [Abstract] [PDF]
|
|
|
|
|
|
E. Delpon, C. Valenzuela, O. Perez, O. Casis, and J. Tamargo Propafenone Preferentially Blocks the Rapidly Activating Component of Delayed Rectifier K+ Current in Guinea Pig Ventricular Myocytes : Voltage-Independent and Time-Dependent Block of the Slowly Activating Component Circ. Res., February 1, 1995; 76(2): 223 - 235. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
